FacultyFaculty/Author Profile
Lisa M. Ferri

Lisa M. Ferri

Mayer Brown LLP
Partner
New York, NY, USA


Lisa M. Ferri is a partner in Mayer Brown’s Intellectual Property practice and serves as the IP Practice Leader for the New York Office. She focuses her practice on the trial and appeal of patent litigation in the Life Sciences field, including representing innovator companies in cases brought pursuant to the Hatch-Waxman Act.  Lisa serves as lead counsel on behalf of high-profile companies in federal courts across the country, Patent Office inter partes reviews, the International Trade Commission and the Federal Circuit Court of Appeals.  Following enactment of the AIA, Lisa handled one of the first co-pending inter partes reviews and district court litigations relating to the Orange Book listed drug Lexiva® -- which was the first “lead compound” IPR before the PTAB as well.

Lisa is an adjunct professor at Fordham University School of Law where she teaches Patent Litigation.

Lisa was named one of the “Top 250 Women in IP” by Managing Intellectual Property and an “IP Star” and “Life Sciences Star” by the Legal Media Group.  Lisa was nominated in 2014 as "Hatch-Waxman Litigator of the Year" by the LMG Life Sciences Awards. In addition, she has been recognized in the area of patent litigation by the Legal 500. Her recent victory at the Federal Circuit Court of Appeals in Biogen IDEC, Inc. and Genentech v. GlaxoSmithKline, which involved the monoclonal antibody therapy Arzerra®, was shortlisted for "Patent Impact Case of the Year" by the LMG Life Sciences Awards.
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.